Dr. Klein is a Senior Research Scientist in the Department of Genetics and the Director/Co-Principal Investigator for the
PharmGKB. She was recruited from the University of California, San Francisco faculty and has been the Director
of the PharmGKB since it began in April 2000. Teri received her PhD in medical information sciences from the
University of California, San Francisco and a BA in biology/chemistry from the University of California,
Santa Cruz. Prior to becoming the director of the PharmGKB in 2000, Dr. Klein was an Associate Adjunct Professor
Teri Klein is a paid scientific advisor to the Rxight™ Pharmacogenetic Program.
Tianyun's research interests lie in drug repurposing and personalization through structural biology and systems biology approaches. In particular, her focus is on relating the genetic features of patients to acquired genes and pathway dependencies and identifying small-molecule drugs that target them.
Emily Mallory is a PhD Candidate in the Biomedical Informatics program. She is interested in both the extraction of biomedical information from text and using this text-derived information in machine learning models.
Weizhuang is a PhD student in the Bioengineering Department at Stanford. His research involves applying machine learning to transciptomic data in order to provide actionable outcomes in precision medicine. Outside of lab, Weizhuang works as a pro bono food critic, but practices restrain and compassion by not leaving any Yelp reviews...
Wen is a PhD student in Bioengineering. Her research interests mainly focus on applying deep learning networks, including 3D convolutional networks, sparse-denoised autoencoders, graph convolutions, and recurrent neural networks to protein 3D structural studies and protein-drug interactions predictions.
Lichy is an MD/PhD student, doing her PhD in Biomedical Informatics. Prior to Stanford, she double majored in biomedical engineering and applied math at Johns Hopkins University. Her research interests revolve around developing methods for elucidating molecular mechanisms of disease and drug response.
Hunter Boyce received his B.S. in Bioinformatics from UC San Diego and is currently a 2nd year PhD student in the Stanford Biomedical Informatics training program. He is working with Dr. Parag Mallick and Dr. Russ Altman on using integrative, multi-omic approaches to model the processes that govern proteome dynamics and to use those models to discover cancer biomarkers and mechanisms.
Ben is a post-doctoral research fellow at the Altman's lab. His previous research was focusing on chemical and computational approach to dissect the cell cycle and the discovery of antimitotic drugs. His current research interest is in the developing and application of novel computational methods for predicting drug actions, interactions, side-effects and repurposing to engineer effective medicine.